Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
| Form | Size | Price | $/mg | Stock | Updated |
|---|---|---|---|---|---|
| vial | 10mg | $49.99 | $5.00/mg | In stock | Jul 27 |
Single-vial list prices — bulk or bundle orders may be lower. Verify at vendor before purchase.
| Lot / Report | Tested | Purity | Lab | Panels | Status | |
|---|---|---|---|---|---|---|
| Black Cap | May 2026 | 99.6% | Freedom Diagnostics | — | Confirmed | View |
Removed from Category 2 on April 22, 2026; in no FDA category today. On the July 23–24, 2026 PCAC advisory docket for cerebral ischemia, migraine, trigeminal neuralgia — not authorized for compounding. The FDA removed 12 substances from Category 2 effective April 22, 2026 because the nominations were withdrawn by the nominators, not because the FDA cleared anything — removal does not place a substance in Category 1 or on the 503A bulks list, so these compounds now sit in no FDA category at all. The Pharmacy Compounding Advisory Committee is advisory only — it met July 23–24, 2026 (docket FDA-2025-N-6895) to review nominations and make recommendations, and the FDA issues any final rule later, typically 6–18 months afterward. Listing decisions are specific to the proposed use.
Does Rescue Research USA sell Semax?
Yes — Rescue Research USA currently lists Semax in 1 variant starting at $49.99 ($5.00/mg).
Is Rescue Research USA's Semax third-party tested?
Yes — Disclosed Labs has indexed 1 Certificate of Analysis for Rescue Research USA's Semax, with the most recent showing 99.6% purity. Rescue Research USA holds an overall trust grade of C (73/100) across all 31 COAs on file.
What is Rescue Research USA's trust grade for Semax?
Rescue Research USA has an overall Disclosed Labs trust grade of C (73/100), computed from 31 COAs across all peptides. The most recent Semax COA was issued by Freedom Diagnostics.
Where is the cheapest Semax?
As of the latest data, IDUN Peptides offers Semax at $1.80/mg — compare with Rescue Research USA's listing at $5.00/mg. See the full Semax price comparison.
What is the FDA compounding status of Semax?
Removed from Category 2 on April 22, 2026; in no FDA category today. On the July 23–24, 2026 PCAC advisory docket for cerebral ischemia, migraine, trigeminal neuralgia — not authorized for compounding. The FDA removed 12 substances from Category 2 effective April 22, 2026 because the nominations were withdrawn by the nominators, not because the FDA cleared anything — removal does not place a substance in Category 1 or on the 503A bulks list, so these compounds now sit in no FDA category at all. The Pharmacy Compounding Advisory Committee is advisory only — it met July 23–24, 2026 (docket FDA-2025-N-6895) to review nominations and make recommendations, and the FDA issues any final rule later, typically 6–18 months afterward. Listing decisions are specific to the proposed use. Sales tracked here are for research purposes only. Disclosed Labs does not provide medical or legal advice.